1
|
Quan AL, Videtic GM and Suh JH: Brain
metastases in small cell lung cancer. Oncology (Williston Park).
18:961–972; discussion 974, 979–80, 987. 2004.PubMed/NCBI
|
2
|
Saito Y, Hayakawa K, Mitsuhashi N, et al:
Late relapse of small cell lung cancer treated with radiation
therapy alone - case report. Lung Cancer. 10:319–324. 1994.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Luketich JD, Martini N, Ginsberg RJ, et
al: Successful treatment of solitary extracranial metastases from
non-small cell lung cancer. Ann Thorac Surg. 60:1609–1611. 1995.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Shahidi H and Kvale PA: Long-term survival
following surgical treatment of solitary brain metastasis in
non-small cell lung cancer. Chest. 109:271–276. 1996. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kagohashi K, Satoh H, Yamashita YT and
Sekizawa K: Brain metastasis as the first manifestation of lung
cancer. Am J Med. 114:4202003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Niiranen A: Long-term survival in small
cell carcinoma of the lung. Eur J Cancer Clin Oncol. 24:749–752.
1988. View Article : Google Scholar : PubMed/NCBI
|
7
|
Johnson BE, Linnoila RI, Williams JP, et
al: Risk of second aerodigestive cancers increases in patients who
survive free of small-cell lung cancer for more than 2 years. J
Clin Oncol. 13:101–111. 1995.PubMed/NCBI
|
8
|
Lassen U, Osterlind K, Hansen M, et al:
Long-term survival in small-cell lung cancer. Posttreatment
characteristics in patients surviving 5 to 18+ years - an analysis
of 1,714 consecutive patients. J Clin Oncol. 13:1215–1220.
1995.PubMed/NCBI
|
9
|
Kitamoto Y, Hayakawa K, Mitsuhashi N, et
al: Redevelopment of small cell lung cancer after a long
disease-free period: a case report. Jpn J Clin Oncol. 32:30–32.
2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Al-Ajam M, Seymour A, Mooty M and Leaf A:
Ten years of disease-free survival between two diagnoses of
small-cell lung cancer: A case report and a literature review. Med
Oncol. 22:89–97. 2005.PubMed/NCBI
|
11
|
Matsui K, Sawa T, Suzuki H, et al: Relapse
of stage I small cell lung cancer ten or more years after the start
of treatment. Jpn J Clin Oncol. 36:457–461. 2006.PubMed/NCBI
|
12
|
Arepally G, Kenyon LC and Lavi E: Late
onset of isolated central nervous system metastasis of liposarcoma
- a case report. Am J Clin Oncol. 19:351–355. 1996. View Article : Google Scholar : PubMed/NCBI
|
13
|
Issa CM, Semrau R, Kath R and Höffken K:
Isolated brain metastases as the sole manifestation of a late
relapse in breast cancer. J Cancer Res Clin Oncol. 128:61–63. 2002.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Shtivelman E: A link between metastasis
and resistance to apoptosis of variant small cell lung carcinoma.
Oncogene. 14:2167–2173. 1997. View Article : Google Scholar : PubMed/NCBI
|
15
|
Blanchard P and Le Péchoux C: Prophylactic
cranial irradiation in lung cancer. Curr Opin Oncol. 22:94–101.
2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Fonseca R, O'Neill BP, Foote RL, et al:
Cerebral toxicity in patients treated for small cell carcinoma of
the lung. Mayo Clin Proc. 74:461–465. 1999. View Article : Google Scholar : PubMed/NCBI
|
17
|
Welzel T, Niethammer A, Mende U, et al:
Diffusion tensor imaging screening of radiation-induced changes in
the white matter after prophylactic cranial irradiation of patients
with small cell lung cancer: first results of a prospective study.
AJNR Am J Neuroradiol. 29:379–383. 2008. View Article : Google Scholar
|
18
|
Wolfson AH, Bae K, Komaki R, et al:
Primary analysis of a phase II randomized trial Radiation Therapy
Oncology Group (RTOG) 0212: impact of different total doses and
schedules of prophylactic cranial irradiation on chronic
neurotoxicity and quality of life for patients with limited-disease
small-cell lung cancer. Int J Radiat Oncol Biol Phys. 81:77–84.
2011.
|
19
|
Le Péchoux C, Laplanche A, Faivre-Finn C,
et al; Prophylactic Cranial Irradiation (PCI) Collaborative Group.
Clinical neurological outcome and quality of life among patients
with limited small-cell cancer treated with two different doses of
prophylactic cranial irradiation in the intergroup phase III trial
(PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol.
22:1154–1163. 2011.
|